Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19349854rdf:typepubmed:Citationlld:pubmed
pubmed-article:19349854lifeskim:mentionsumls-concept:C2239176lld:lifeskim
pubmed-article:19349854lifeskim:mentionsumls-concept:C0002598lld:lifeskim
pubmed-article:19349854lifeskim:mentionsumls-concept:C0031928lld:lifeskim
pubmed-article:19349854lifeskim:mentionsumls-concept:C0796679lld:lifeskim
pubmed-article:19349854lifeskim:mentionsumls-concept:C0071126lld:lifeskim
pubmed-article:19349854lifeskim:mentionsumls-concept:C1519810lld:lifeskim
pubmed-article:19349854pubmed:issue3lld:pubmed
pubmed-article:19349854pubmed:dateCreated2009-11-6lld:pubmed
pubmed-article:19349854pubmed:abstractTextFurther to a previous study whereby we reported that an in vitro emulsion of pirarubicin, amiodarone, and lipiodol was more stable and cytotoxic than a classic doxorubicin-lipiodol mixture, we designed a pilot study to evaluate efficacy and toxicity of a transarterial chemoembolization (TACE) procedure using a combination of pirarubicin, amiodarone, lipiodol, and gelatin sponge.lld:pubmed
pubmed-article:19349854pubmed:languageenglld:pubmed
pubmed-article:19349854pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19349854pubmed:citationSubsetIMlld:pubmed
pubmed-article:19349854pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19349854pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19349854pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19349854pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19349854pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19349854pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19349854pubmed:statusMEDLINElld:pubmed
pubmed-article:19349854pubmed:monthJunlld:pubmed
pubmed-article:19349854pubmed:issn1537-453Xlld:pubmed
pubmed-article:19349854pubmed:authorpubmed-author:ChauffertBrun...lld:pubmed
pubmed-article:19349854pubmed:authorpubmed-author:KrauseDenisDlld:pubmed
pubmed-article:19349854pubmed:authorpubmed-author:HillonPatrick...lld:pubmed
pubmed-article:19349854pubmed:authorpubmed-author:MinelloAnneAlld:pubmed
pubmed-article:19349854pubmed:authorpubmed-author:CercueilJean-...lld:pubmed
pubmed-article:19349854pubmed:authorpubmed-author:GhiringhelliF...lld:pubmed
pubmed-article:19349854pubmed:authorpubmed-author:JouveJean-Lou...lld:pubmed
pubmed-article:19349854pubmed:authorpubmed-author:BedenneLauren...lld:pubmed
pubmed-article:19349854pubmed:authorpubmed-author:GuiuBorisBlld:pubmed
pubmed-article:19349854pubmed:authorpubmed-author:FerrantEmmanu...lld:pubmed
pubmed-article:19349854pubmed:authorpubmed-author:BonnetainFran...lld:pubmed
pubmed-article:19349854pubmed:authorpubmed-author:BoulinMathieu...lld:pubmed
pubmed-article:19349854pubmed:authorpubmed-author:LoffroyRomari...lld:pubmed
pubmed-article:19349854pubmed:authorpubmed-author:GuiuSéverineSlld:pubmed
pubmed-article:19349854pubmed:authorpubmed-author:ColinCédricClld:pubmed
pubmed-article:19349854pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19349854pubmed:volume32lld:pubmed
pubmed-article:19349854pubmed:ownerNLMlld:pubmed
pubmed-article:19349854pubmed:authorsCompleteYlld:pubmed
pubmed-article:19349854pubmed:pagination238-44lld:pubmed
pubmed-article:19349854pubmed:meshHeadingpubmed-meshheading:19349854...lld:pubmed
pubmed-article:19349854pubmed:meshHeadingpubmed-meshheading:19349854...lld:pubmed
pubmed-article:19349854pubmed:meshHeadingpubmed-meshheading:19349854...lld:pubmed
pubmed-article:19349854pubmed:meshHeadingpubmed-meshheading:19349854...lld:pubmed
pubmed-article:19349854pubmed:meshHeadingpubmed-meshheading:19349854...lld:pubmed
pubmed-article:19349854pubmed:meshHeadingpubmed-meshheading:19349854...lld:pubmed
pubmed-article:19349854pubmed:meshHeadingpubmed-meshheading:19349854...lld:pubmed
pubmed-article:19349854pubmed:meshHeadingpubmed-meshheading:19349854...lld:pubmed
pubmed-article:19349854pubmed:meshHeadingpubmed-meshheading:19349854...lld:pubmed
pubmed-article:19349854pubmed:meshHeadingpubmed-meshheading:19349854...lld:pubmed
pubmed-article:19349854pubmed:meshHeadingpubmed-meshheading:19349854...lld:pubmed
pubmed-article:19349854pubmed:meshHeadingpubmed-meshheading:19349854...lld:pubmed
pubmed-article:19349854pubmed:meshHeadingpubmed-meshheading:19349854...lld:pubmed
pubmed-article:19349854pubmed:meshHeadingpubmed-meshheading:19349854...lld:pubmed
pubmed-article:19349854pubmed:meshHeadingpubmed-meshheading:19349854...lld:pubmed
pubmed-article:19349854pubmed:meshHeadingpubmed-meshheading:19349854...lld:pubmed
pubmed-article:19349854pubmed:meshHeadingpubmed-meshheading:19349854...lld:pubmed
pubmed-article:19349854pubmed:meshHeadingpubmed-meshheading:19349854...lld:pubmed
pubmed-article:19349854pubmed:meshHeadingpubmed-meshheading:19349854...lld:pubmed
pubmed-article:19349854pubmed:year2009lld:pubmed
pubmed-article:19349854pubmed:articleTitlePilot study of transarterial chemoembolization with pirarubicin and amiodarone for unresectable hepatocellular carcinoma.lld:pubmed
pubmed-article:19349854pubmed:affiliationDepartments of Interventional Radiology, University Hospital le Bocage, Dijon, France. boris.guiu@chu-dijon.frlld:pubmed
pubmed-article:19349854pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19349854pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed